ストックスクリーナーアプリを入手
14.30
1.63%
0.23
アフターアワーズ：
14.02
-0.28
-1.96%
Keros Therapeutics Inc (KROS) 最新ニュース
197,666 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Acquired by Walleye Capital LLC - MarketBeat
Altium Capital Management LLC Has $2.77 Million Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Major Shareholder Purchases $9,464,033.54 in Stock - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Bought by Vanguard Group Inc. - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Alliancebernstein L.P. - MarketBeat
How the (KROS) price action is used to our Advantage - news.stocktradersdaily.com
124,620 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Acquired by Federated Hermes Inc. - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Keros Therapeutics enters agreement with Pontifax - Investing.com Australia
Keros Therapeutics enters agreement with Pontifax By Investing.com - Investing.com Canada
Norges Bank Invests $1.03 Million in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Stock Traders Purchase Large Volume of Put Options on Keros Therapeutics (NASDAQ:KROS) - MarketBeat
Truist Financial Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $25.00 - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by ADAR1 Capital Management LLC - MarketBeat
KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5% - MSN
Adar1 partners increases stake in Keros Therapeutics with $9.1m purchase - Investing.com Canada
Deal Dispatch: Harley-Davidson To Wipe Out? Plus, Prada's Versace Purchase Garners A Fashionable Price - Benzinga
Keros Therapeutics: Strategic Alternatives Could Bring About Value Creation - Seeking Alpha
Keros Therapeutics (KROS) Reports Positive Phase 1 Results for K - GuruFocus
Keros Therapeutics (KROS) Shows Potential for Upside - GuruFocus
Keros Therapeutics (KROS) Surges Amid Strategic Review and Poiso - GuruFocus
Keros Therapeutics (KROS) Shows Potential with Analyst Optimism - GuruFocus
Adar1 capital management increases stake in Keros Therapeutics with $328k purchase - Investing.com
Keros Therapeutics (KROS) Initiates Strategic Review and Adopts Rights Plan | KROS Stock News - GuruFocus
Keros Therapeutics Announces Review of Strategic Alternatives | KROS Stock News - GuruFocus
Bryce Point Capital LLC Invests $445,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Keros Therapeutics Explores Major Strategic Alternatives With Share Price Jump - Finimize
Keros Therapeutics Shares Rise After Board Initiates Review of Strategic Alternatives - marketscreener.com
Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Benzinga
Keros Therapeutics considers sale amid investor pressure - Yahoo Finance
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - Benzinga
Keros Therapeutics Adopts Defense Strategy Against Potential Hostile Takeover, Explores Sale: Retail’s Overjoyed - MSN
Keros Therapeutics adopts poison pill as it explores options, including sale - MSN
Keros Therapeutics stock jumps on strategic review, potential sale By Investing.com - Investing.com Canada
Keros Therapeutics Considers Sale Amid Strategic Review Process - Finimize
Keros Therapeutics adopts poison pill as shareholders seek control - MSN
Keros Therapeutics Board Initiates Review of Strategic Alternatives - marketscreener.com
Keros stock climbs after strategic review (KROS:NASDAQ) - Seeking Alpha
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):